Keri Hurley-Kim

Keri Hurley-Kim

Auto-generated profile, based on publicly available information

Keri Hurley-Kim

University of California, Irvine School of Pharmacy and Pharmaceutical Sciences, 856 Health Sciences Rd, Irvine, CA 92697, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
ASAryana Sepassi
Aryana Sepassi
JWJiayuan Wang
Jiayuan Wang
SYSophia Yankowski
Sophia Yankowski
AEAya Enkoji
Aya Enkoji
MOMmeridi Okenwa
Mmeridi Okenwa
KHKeri Hurley-Kim
Keri Hurley-Kim
The primary objective of this study is to investigate the associations between long-term metformin use, vitamin B12 status, and peripheral neuropathy. Secondarily, we aim to explore the effect of time since diagnosis on the relationships between metformin use, vitamin B12 deficiency, and peripheral neuropathy. A retrospective observational cross-sectional analysis was conducted using NIH's All of Us database. The risk of vitamin B12 deficiency and peripheral neuropathy was compared among long-term metformin users (≥4 years), short-term users (<4 years), and non-metformin users via a series of unadjusted and adjusted logistic regression models. Among 14,808 adults with type 2 diabetes mellitus (T2DM), 9,136 (61.70 %) used metformin, of whom 5,609 (37.95 %) were long-term users. Following adjustment for confounders, long-term users exhibited a 67 % and 38 % higher likelihood of vitamin B12 deficiency than non-users and short-term users respectively (p < 0.001). Peripheral neuropathy prevalence was 39 % higher among long-term users compared to short-term users (p < 0.001), with a non-statistically significant difference compared to non-users. Long-term metformin use is associated with both an increased risk of vitamin B12 deficiency and peripheral neuropathy in patients with T2DM. Providers should consider routinely assessing vitamin B12 status in long-term users, particularly when evaluating peripheral neuropathy symptoms.

1 January 2023 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
KHKeri Hurley-Kim
Keri Hurley-Kim
AKAzin Keyvani
Azin Keyvani
RARaed Ahmed
Raed Ahmed
HWHei-Wah Wong
Hei-Wah Wong
SMSarah McBane
Sarah McBane
Introduction: Increasing administrative workload is linked with lower quality of patient care and physician burnout. Conversely, models involving pharmacists can positively impact patient care and physician well-being. Research has consistently demonstrated that pharmacist-physician collaboration can improve outcomes for chronic diagnoses. Pharmacist-managed refill services may improve provider workload measures and clinical outcomes. Methods: This was an evaluation of a pharmacist-managed refill service at a Federally Qualified Health Center (FQHC). Under collaborative practice agreement, pharmacists addressed refill requests and recommended interventions. Data analysis evaluated effectiveness of the model, including clinical interventions, and involved descriptive statistics and qualitative approaches. Results: Average patient age was 55.5 years old and 53.1% were female. Turnaround time was within 48 h for 87.8% of refill encounters. During an average of 3.2 h per week, pharmacists addressed 9.2% (n = 1683 individual requests in 1255 indirect patient encounters) of the total clinic refill requests during the 1-year study period. In 453 of these encounters (36.1%), pharmacists recommended a total of 642 interventions. 64.8% of these were need for appointment (n = 211) or labs (n = 205). Drug therapy problems and medication list discrepancies were identified in 12.6% (n = 81) and 11.9% (n = 76) of encounters, respectively. Discussion and Conclusions: The results of this study are consistent with previous literature demonstrating the value of interprofessional collaboration. Pharmacists addressed refills in an efficient, clinically effective manner in an FQHC setting. This may positively impact primary care provider workload, patients’ medication persistence, and clinical care.

13 November 2022 in Journal of the American Pharmacists Association
Verified
Journal Article
Open access
DNDing Quan Ng
Ding Quan Ng
SJStanley Jia
Stanley Jia
CWCheryl Wisseh
Cheryl Wisseh
CCChristine Cadiz
Christine Cadiz
MNMegan Nguyen
Megan Nguyen
KHKeri Hurley-Kim
Keri Hurley-Kim
The National Institutes of Health All of Us (AoU) Research Program is currently building a database of 1million+ adult subjects. With it, we describe the characteristics of those with documented vaccinations. To describe the sociodemographic, health status, and lifestyle factors associated with vaccinations. This is a retrospective study involving data from the AoU program (R2020Q4R2, N = 315,297). Five vaccine cohorts [influenza, hepatitis B (HBV), pneumococcal <65 years old, pneumococcal ≥65 years old, and human papillomavirus (HPV)] were generated based on vaccination history. The influenza cohort comprised participants with documented influenza vaccinations in electronic health records (EHRs) from September 2017 to May 2018. Other vaccine cohorts comprised participants with ≥1 lifetime record(s) of vaccination documented in the EHR by December 2018. The vaccine cohorts were compared to the overall AoU cohort. Descriptive statistics were generated using EHR- and survey-based sociodemographic, health, and lifestyle information. The SAMBA (0.9.0) R package was utilized to adjust for EHR selection and outcome misclassification biases to infer sources of disparity for pneumococcal vaccinations in older adults. Cohort counts were as follows: influenza (n = 15,346), HBV (n = 6323), pneumococcal <65 (n = 15,217), pneumococcal ≥65 (n = 15,100), and HPV (n = 2125). All vaccine cohorts had higher proportions of White and non-Hispanic/Latino participants compared to the overall AoU cohort. The largest differences were found in pneumococcal age ≥65, with 80.2% White participants compared to 52.9% in the overall study population. Multivariable analysis revealed that race/ethnic disparities in pneumococcal vaccination among older adults were explained by biological sex, income, health insurance, and education-related variables. Racial, ethnic, education, and income characteristics differ across the vaccine cohorts among AoU participants. These findings inform future utilization of large health databases in vaccine epidemiology research and emphasize the need for more targeted interventions that address differences in vaccine uptake.

9 June 2022 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
AOAya F. Ozaki
Aya F. Ozaki
CCChristine L. Cadiz
Christine L. Cadiz
KHKeri Hurley‐Kim
Keri Hurley‐Kim
CWCheryl Wisseh
Cheryl Wisseh
EKErin D. Knox
Erin D. Knox
ACAlexandre Chan
Alexandre Chan